Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders.
|Title||Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders.|
|Publication Type||Journal Article|
|Year of Publication||2005|
|Authors||Abikoff, H, McGough J, Vitiello B, McCracken J, Davies M, Walkup J, Riddle M, Oatis M, Greenhill L, Skrobala A, March J, Gammon P, Robinson J, Lazell R, McMahon DJ, Ritz L|
|Corporate Authors||RUPP ADHD/Anxiety Study Group|
|Journal||Journal of the American Academy of Child and Adolescent Psychiatry|
|Date Published||2005 May|
|Keywords||Adolescent, Anxiety Disorders, Attention Deficit Disorder with Hyperactivity, Central Nervous System Stimulants, Child, Comorbidity, Dose-Response Relationship, Drug, Double-Blind Method, Female, Fluvoxamine, Humans, Male, Methylphenidate, Serotonin Uptake Inhibitors|
Attention-deficit/hyperactivity disorder (ADHD) is often accompanied by clinically significant anxiety, but few empirical data guide treatment of children meeting full DSM-IV criteria for ADHD and anxiety disorders (ADHD/ANX). This study examined the efficacy of sequential pharmacotherapy for ADHD/ANX children.
|Alternate Journal||J Am Acad Child Adolesc Psychiatry|